Clinical Trial Update: Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial [Phase 2]

View source ↗

Summary

COGIT-2 is a Phase 2 clinical trial led by Columbia University evaluating cognitive training to enhance neuroplasticity in individuals with mild cognitive impai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Snippet

Sponsor: Columbia University | Conditions: Mild Cognitive Impairment (MCI), Cognitive Training | Phase 2 | Status: RECRUITING